Advertisement

Topics

Active Biotech AB Year-end report January - December 2017

03:30 EST 15 Feb 2018 | GlobalNewsWire (2014)

This article has expired, however you can still download the PDF.
Preview:
Fourth quarter in brief The primary clinical endpoint was not met in the Phase II study (ARPEGGIO) with laquinimod in PPMS Patent regarding tasquinimod for the treatment of acute leukemia granted in Europe The process to divest the company&...

Other Sources for this Article

NEXT ARTICLE

More From BioPortfolio on "Active Biotech AB Year-end report January - December 2017 "

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...